Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
39
CRSP Quote, Financials, Valuation and Earnings
Last price:
$55.02
Seasonality move
:
-17.77%
Day range:
$53.40 - $55.33
52-week range:
$30.04 - $63.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.60x
Volume:
3.3M
Avg. volume:
3.5M
1-year change:
-12.13%
Market cap:
$4.8B
Revenue:
$35M
EPS (TTM):
-$4.52
CRISPR Therapeutics AG SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
CRSP
CRISPR Therapeutics AG
|
11/06/2023 | 10-Q | 10-Q filing on 11/06/2023 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/07/2023 | 10-Q | 10-Q filing on 08/07/2023 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/08/2023 | 10-Q | 10-Q filing on 05/08/2023 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/01/2022 | 10-Q | 10-Q filing on 11/01/2022 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/08/2022 | 10-Q | 10-Q filing on 08/08/2022 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/09/2022 | 10-Q | 10-Q filing on 05/09/2022 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/03/2021 | 10-Q | 10-Q filing on 11/03/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
07/29/2021 | 10-Q | 10-Q filing on 07/29/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
04/27/2021 | 10-Q | 10-Q filing on 04/27/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
02/16/2021 | 10-K | 10-K filing on 02/16/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
10/28/2020 | 10-Q | 10-Q filing on 10/28/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
07/27/2020 | 10-Q | 10-Q filing on 07/27/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
04/28/2020 | 10-Q | 10-Q filing on 04/28/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
02/12/2020 | 10-K | 10-K filing on 02/12/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
10/28/2019 | 10-Q | 10-Q filing on 10/28/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
07/29/2019 | 10-Q | 10-Q filing on 07/29/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
04/29/2019 | 10-Q | 10-Q filing on 04/29/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
02/25/2019 | 10-K | 10-K filing on 02/25/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/07/2018 | 10-Q | 10-Q filing on 11/07/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/07/2018 | 10-Q | 10-Q filing on 08/07/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/08/2018 | 10-Q | 10-Q filing on 05/08/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
03/08/2018 | 10-K | 10-K filing on 03/08/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/08/2017 | 10-Q | 10-Q filing on 11/08/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/10/2017 | 10-Q | 10-Q filing on 08/10/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/11/2017 | 10-Q | 10-Q filing on 05/11/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
03/10/2017 | 10-K | 10-K filing on 03/10/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/22/2016 | 10-Q | 10-Q filing on 11/22/2016 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
